LACTEOL FORT SACHET
Country: Singapore
Language: English
Source: HSA (Health Sciences Authority)
Summary of Product characteristics
(SPC)
16-10-2018
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
CULTURE MEDIUM (NEUTRALIZED AND LYOPHILIZED); LACTOBACILLUS LB (LYOPHILIZED MICROBIAL BODIES)
Available from:
AMSCO HEALTHCARE MARKETING PTE. LTD.
ATC code:
A07FA01
Dosage:
160 mg/sachet
Pharmaceutical form:
POWDER
Composition:
CULTURE MEDIUM (NEUTRALIZED AND LYOPHILIZED) 160 mg/sachet; LACTOBACILLUS LB (LYOPHILIZED MICROBIAL BODIES) 10 billions/sachet
Administration route:
ORAL
Prescription type:
General Sale List
Manufactured by:
ADARE PHARMACEUTICALS SAS
Authorization status:
ACTIVE
Authorization date:
1998-05-27
Summary of Product characteristics
The 2nd dose can be taken 6-8 hours after the 1st dose.
Usage during pregnancy
No known teratogenic effect has been reported.
Adverse side effects
No side effect has been so far reported.
Incompatibilities and interactions
No known incompatibilities and drug interactions
have been reported.
Stability and storage
Shelf life: 3 years
Keep in cool dry place, store below 25°C
Non-poison drug
Dosage and administration
To be taken at the first sign of diarrhoea.
ADARE PHARMACEUTICALS SAS
Route de Bû- 78550 Houdan, FRANCE
Presentation
Strip-seal: Boxes of 6, 100 sachets.
Composition (1 sachet)
• Lactobacillus LB
(lyophilized inactive microbial bodies) ........................ 10
billion
• Fermented culture medium (neutralized) .................... 160mg
Excipients: Lactose monohydrate, calcium carbonate, silicic
acid, banana-orange flavour, saccharose, q.s ........... 800mg
Pharmacological properties
Antidiarrheal of microbial origin, with:
• Direct bacteriostatic action and stimulation of the growth of
the defensive acidogenic intestinal flora,
• Non-specific immunostimulation of the mucosa (increased
synthesis of IgA),
• Inhibition of adherence of invasive or toxinogenic
enteropathogenic organisms (Escherichia Coli,
Campylobacter Jejuni) to epithelial cells.
Indications
Symptomatic treatment of diarrhoea.
Disposal of product
Discard the sachets after the expiry date and throw contents
into the dustbin.
_Information contained in leaflet is limited and further information
can be _
_obtained from other sources, including the doctor and the
pharmacist._
Read the complete document
